A phase II study of chemotherapy of meta
β
Robert P. Whitehead; Thomas R. Fleming; John S. Macdonald; Frederick R. Ahmann;
π
Article
π
1991
π
Springer US
π
English
β 205 KB
The combination of 5-fluorouracil and cisplatin has shown encouraging results in single institution pilot studies in colorectal carcinoma. This phase II SWOG study was undertaken to further evaluate this treatment. Cisplatin was administered at a dose of 60 mg/M2 IV day 1, repeated every 21 days. 5-